Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06071754 · ClinicalTrials.gov registry record · NA
Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057
A NA study, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 365
- Enrollment target
NCT06071754: Completed NA study, sponsored by Masimo Corporation.
NCT06071754 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 365 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06071754, a NA study, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 365 participants
- Enrollment target
Study Summary
The objective of this study is to validate the performance of the electrocardiogram (ECG) function of the Masimo INVSENSOR00057 against contemporaneous measurements
Primary Outcome
Single Lead ECG, similar to lead I, intended to be used for Heart Rate measurement and AFib detection
Interventions
- DEVICE Masimo INVSENSOR00057
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
What the finished NCT06071754 record still lists
NCT06071754 is an interventional study that assigns participants to a tested intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which Masimo INVSENSOR00057 is the first listed.
NCT06071754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06071754 about?
NCT06071754 is a clinical study titled "Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057". The objective of this study is to validate the performance of the electrocardiogram (ECG) function of the Masimo INVSENSOR00057 against contemporaneous measurements
What is the current status of trial NCT06071754?
This trial is currently completed. It is a NA study. The enrollment target is 365 participants. The study started on 2023-09-01. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT06071754?
The interventions under investigation include: Masimo INVSENSOR00057 (DEVICE).
Who is sponsoring clinical trial NCT06071754?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06071754's enrollment target sits among peer trials
365 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI